Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Credit Suisse Doubtful About Cinemark's Box Office Recovery in 2023

Published 12/10/2022, 18:08
Updated 12/10/2022, 18:08
© Reuters.

© Reuters.

By Sam Boughedda

Cinemark Holdings (NYSE:CNK) was double-downgraded to Underperform from Outperform, with the price target cut to $9 from $25 by Credit Suisse on Wednesday.

Analysts there said while many industry participants have expressed optimism that the 2023 U.S. box office will continue its post-pandemic recovery, they are doubtful.

"We built a bottom-up film forecast and see industrywide domestic box office revenue up about 4% in 2023. This is in part due to Paramount's next Star Trek release having been pushed to 2024 and our presumption Disney's Blade will be similarly delayed, but also due tough comps with the top titles of 2022," wrote the analysts.

In addition, Credit Suisse sees "softness in 1Q23 and 4Q23" while believing summer 2023 should see offsetting gains. In addition, it is forecasting 4Q22 domestic box flat, below consensus.

"Following a comprehensive update of our Cinemark forecast, we shift to well-below-consensus estimates, including EBITDA of $113M for 4Q22 (vs. Street $128M) and $417M for 2023 (vs. Street $569M), while we lower ‘22/’23 EPS about $1 to - $0.41/$0.11. Our 3Q22 EBITDA of $92M is similar to the Street’s $93M. We do not forecast a material further recovery towards pre-pandemic levels in 2024 and beyond; rather, we trendline long-term historically secular dynamics off our 2023 base," the analysts added.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.